Activities per year
Activities
- 26 results
Search results
-
The Highest EBV DNA Copy Numbers are Detected in Untreated Patients with the High-Risk Chronic Lymphocytic Leukemia
Holodņuka, I. (Speaker)
9 Nov 2023Activity: Talk or presentation types › Oral presentation
File -
Investigation of the Epstein-Barr virus infection in untreated patients with chronic lymphocytic leukemia in Latvia
Holodņuka, I. (Co-author)
11 Sept 2023 → 13 Sept 2023Activity: Talk or presentation types › Poster presentation
-
EBV Infection Promotes Migration of The Host B Cells Via Up-Regulation of The Inflammatory Chemokine Receptors CCR1 and CCR2
Holodņuka, I. (Speaker)
15 Jun 2023Activity: Talk or presentation types › Oral presentation
-
Mutations within the chemokine receptor CCR2 gene coding region in patients with chronic lymphocytic leukemia
Zvejniece, L. (Speaker), Rudevica, Ž. (Co-author), Leonciks, A. (Co-author), Rivkina, A. (Co-author), Holodņuka, I. (Co-author) & Lejniece, S. (Co-author)
29 Mar 2023 → 31 Mar 2023Activity: Talk or presentation types › Poster presentation
-
RSU International Research Conference 2023: Knowledge for Use in Practice
Nora-Krūkle, Z. (Scientific committee member), Vīksna, L. (Scientific committee member), Kroiča, J. (Scientific committee member), Zavadska, D. (Scientific committee member), Kadiša, A. (Scientific committee member), Kurjāne, N. (Scientific committee member), Skadiņš, I. (Scientific committee member), Pētersons, A. (Scientific committee member), Ķēniņa, V. (Scientific committee member), Schneider, M. (Scientific committee member), Gilburd, B. (Scientific committee member), Murovska, M. (Scientific committee member), Sultanova, A. (Scientific committee member), Holodņuka, I. (Scientific committee member), Rasa-Dzelzkalēja, S. (Scientific committee member), Koļesova, O. (Scientific committee member) & Svirskis, Š. (Scientific committee member)
29 Mar 2023 → 31 Mar 2031Activity: Participating in or organising an event types › Organising a conference, workshop, ...
-
Association of Prognostic Leukemic Cell Surface Markers with the Mutation Status of the Immunoglobulin Heavy Chain Variable Region Genes in Untreated Patients with Chronic Lymphocytic Leukemia
Nazarenko, M. (Speaker), Zvejniece, L. (Co-author), Rivkina, A. (Co-author), Korņilova, O. (Co-author), Svirskis, Š. (Co-author), Gorbačova, V. (Co-author), Pavlova, J. (Co-author), Leonciks, A. (Co-author), Lejniece, S. (Co-author) & Holodņuka, I. (Co-author)
29 Mar 2023 → 31 Mar 2023Activity: Talk or presentation types › Poster presentation
-
EBV Infection and Disease Progression Cell-Surface Markers in Latvian Cohort of Untreated Patients with Chronic Lymphocytic Leukemia
Holodņuka, I. (Speaker), Kozireva, S. (Co-author), Rivkina, A. (Co-author), Zvejniece, L. (Co-author), Korņilova, O. (Co-author), Pavlova, J. (Co-author), Murovska, M. (Co-author) & Lejniece, S. (Co-author)
29 Mar 2023 → 31 Mar 2023Activity: Talk or presentation types › Poster presentation
-
MDPI Multidisciplinary Digital Publishing Institute (Publisher)
Holodņuka, I. (Reviewer of journal article)
16 Feb 2023 → 10 Mar 2023Activity: Publication peer-review and editorial work types › Publication Peer-review
-
MDPI Multidisciplinary Digital Publishing Institute (Publisher)
Holodņuka, I. (Reviewer of journal article)
18 Nov 2022Activity: Publication peer-review and editorial work types › Publication Peer-review
-
International Journal of Molecular Sciences (Journal)
Holodņuka, I. (Reviewer of journal article)
5 Oct 2022 → 13 Oct 2022Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Multicolor Flow Cytometry Part II
Holodņuka, I. (Speaker)
17 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Multicolor Flow Cytometry Part I
Holodņuka, I. (Speaker)
16 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Biomedicines (Journal)
Holodņuka, I. (Reviewer of journal article)
14 Feb 2022 → 27 Feb 2022Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Viruses (Journal)
Holodņuka, I. (Reviewer of journal article)
16 Nov 2021 → 5 Jan 2022Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Proportions of the Peripheral Blood Mononuclear Cells in Patients with Rheumatoid Arthritis
Holodņuka, I. (Speaker)
28 Oct 2021Activity: Talk or presentation types › Oral presentation
-
CHEMOKINE RECEPTORS CCR1 AND CCR2 ARE UP-REGULATED ON CIRCULATING LEUKEMIC CELLS OF THE UNTREATED CD38+ CLL PATIENTS WITH THE HIGH EBV DNA-COPY LOAD
Holodņuka, I. (Speaker)
16 Sept 2021Activity: Talk or presentation types › Poster presentation
-
CHEMOKINE RECEPTORS CCR1 AND CCR2 ON CIRCULATING LYMPHOCYTES IN UNTREATED CLL PATIENTS WITH ANEMIA AND IMMUNE THROMBOCYTOPENIA
Holodņuka, I. (Speaker)
29 May 2021Activity: Talk or presentation types › Poster presentation
-
Inflammatory chemokine receptors in Epstein–Barr virus infection
Holodņuka, I. (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Inflammatory Chemokine Receptors in EBV Infection
Holodņuka, I. (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Cancers (Journal)
Holodņuka, I. (Reviewer of journal article)
29 Aug 2020 → 30 Oct 2020Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Cancers (Journal)
Holodņuka, I. (Reviewer of journal article)
16 Jun 2020 → 4 Aug 2020Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Scientific Council of the Institute of Microbiology and Virology of the Rīga Stradiņš University (Organisational unit)
Holodņuka, I. (Member)
15 Mar 2019 → …Activity: Membership types › Membership of council
-
Biocruces Bizkaia Health Research Institute
Holodņuka, I. (Visiting lecturer)
25 Feb 2019Activity: Visiting an external institution types › Visiting an external academic institution
-
COST Action CA17103 "Delivery of Antisense RNA Therapeutics" (External organisation)
Holodņuka, I. (Member)
23 Oct 2018 → 22 Apr 2023Activity: Membership types › Membership of network
-
Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines
Holodņuka, I. (Speaker)
24 Jun 2017 → 27 Jun 2017Activity: Talk or presentation types › Poster presentation
File -
COST action CA16120 "European Epitranscriptomics Network" (EPITRAN) (External organisation)
Holodņuka, I. (Member)
29 Mar 2017 → 28 Sept 2021Activity: Membership types › Membership of network